EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peripheral alpha 2-adrenergic antagonist vatinoxan improves the quality of medetomidine–midazolam sedation in Wistar rats

Emily Lindh, Anna Meller, Karoliina Alm, Piet Finckenberg, Marja Raekallio, Juhana Honkavaara

Veterinary Anaesthesia and Analgesia · 2025

DOI: 10.1016/j.vaa.2025.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2025. Verfasst von Emily Lindh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. Electronic address: emily.…. Hauptthemen laut MEDLINE: Medetomidine, Midazolam, Hypnotics and Sedatives, Adrenergic alpha-2 Receptor Antagonists. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetcare Oy, Suomen Eläinlääketieteen Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the effects of a peripheral alpha 2-adrenoceptor antagonist, vatinoxan, on medetomidine-midazolam sedation in adult Wistar rats. STUDY DESIGN: Randomized, blinded, crossover study (7 day rest period between treatments). ANIMALS: A group of 10 male adult Wistar rats weighing 311-332 g. METHODS: Rats were administered four subcutaneous (SC) treatments: medetomidine 0.25 mg kg-1 and midazolam 2 mg kg-1 (MM), medetomidine 0.125 mg kg-1 and midazolam 1 mg kg-1 (½MM), MM + vatinoxan 5 mg kg-1 (MMV) or ½MM + vatinoxan 2.5 mg kg-1 (½MMV). The time to loss of consciousness was determined by measuring the time to loss of the righting reflex. Noninvasive mean arterial blood pressure (MAP) and pulse rate were measured. After 55 minutes, blood glucose concentration (BGC) was analysed and atipamezole (1.25 mg kg-1 or 0.625 mg kg-1) and flumazenil (0.2 mg kg-1) were injected SC. RESULTS: The time to loss of consciousness (seconds) was significantly shorter after MMV [152 (122-189)] [median (range)] than after MM [172 (108-325)] or ½MM [243 (140-508)] (p = 0.050, p = 0.001). BGC (mmol L-1) was significantly lower after MMV (9.6 ± 1.8, mean ± standard deviation) and ½MMV (9.7 ± 1.8) than after MM (18.1 ± 4.1) or ½MM (17.3 ± 2.4) (all p < 0.001). No mortality, hypotension (MAP < 60 mmHg) or hypoglycaemia (BCG < 4.0) were detected after any treatment. CONCLUSIONS AND CLINICAL RELEVANCE: By mitigating the medetomidine-associated effects outside of the central nervous system and reducing the time to loss of consciousness, vatinoxan improved the quality of SC medetomidine-midazolam sedation in laboratory rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedetomidineMidazolamHypnotics and SedativesAdrenergic alpha-2 Receptor AntagonistsQuinolizinesProcedural SedationAnimalsRats, WistarMaleRatsCross-Over StudiesFlumazenil

Stichwörter der Autor:innen

hyperglycaemiahypertensionmedetomidinemidazolamratsvatinoxan

Substanzen

MedetomidineMidazolamHypnotics and SedativesvatinoxanAdrenergic alpha-2 Receptor AntagonistsQuinolizinesFlumazenil

Autor:innen und Institutionen

  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. Electronic address: emily.lindh@helsinki.fi.
  • Laboratory Animal Centre, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.

Förderung

  • Vetcare Oy
  • Suomen Eläinlääketieteen Säätiö

Zitieren

APA

Lindh, E., Meller, A., Alm, K., Finckenberg, P., Raekallio, M., & Honkavaara, J. (2025). Peripheral alpha 2-adrenergic antagonist vatinoxan improves the quality of medetomidine–midazolam sedation in Wistar rats. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2025.04.002

Vancouver

Lindh E, Meller A, Alm K, Finckenberg P, Raekallio M, Honkavaara J. Peripheral alpha 2-adrenergic antagonist vatinoxan improves the quality of medetomidine–midazolam sedation in Wistar rats. Veterinary Anaesthesia and Analgesia. 2025. doi:10.1016/j.vaa.2025.04.002

BibTeX
@article{Lindh2025,
  author = {Lindh, Emily and Meller, Anna and Alm, Karoliina and Finckenberg, Piet and Raekallio, Marja and Honkavaara, Juhana},
  title = {Peripheral alpha 2-adrenergic antagonist vatinoxan improves the quality of medetomidine–midazolam sedation in Wistar rats},
  journal = {Veterinary Anaesthesia and Analgesia},
  year = {2025},
  doi = {10.1016/j.vaa.2025.04.002}
}
Kostenlos starten →